Conference proceedings

How Wnt signaling affects bone repair by mesenchymal stem cells from the bone marrow

Gregory C, Gunn W, Reyes E, Smolarz A, Munoz J, Spees J, Prockop D ...see all

Annals of the New York Academy of Sciences, vol. 1049 (2005) pp. 97-106

  • 46

    Readers

    Mendeley users who have this article in their library.
  • 104

    Citations

    Citations of this article.
  • N/A

    Views

    ScienceDirect users who have downloaded this article.
Sign in to save reference

Abstract

Human mesenchymal stem cells (hMSCs) from bone marrow are a source of osteoblast progenitors in vivo, and under appropriate conditions they differentiate into osteoblasts ex vivo. The cells provide a convenient cell culture model for the study of osteogenic tissue repair in an experimentally accessible system. Recent advances in the field of skeletal development and osteogenesis have demonstrated that signaling through the canonical wingless (Wnt) pathway is critical for the differentiation of progenitor cell lines into osteoblasts. Inhibition of such signals can predispose hMSCs to cell cycle entry and prevent osteogenesis. Our investigation of the role of Wnt signaling in osteogenesis by hMSCs ex vivo has demonstrated that osteogenesis proceeds in response to bone morphogenic protein 2 stimulation and is sustained by Wnt signaling. In the presence of Dkk-1, an inhibitor of Wnt signaling, the cascade is disrupted, resulting in inhibition of osteogenesis. Peptide mapping studies have provided peptide Dkk-1 agonists and the opportunity for the production of blocking antibodies. Anti-Dkk-1 strategies are clinically relevant since high serum levels of Dkk-1 are thought to contribute to osteolytic lesion formation in multiple myeloma and possibly some forms of osteosarcoma. Specific inhibitors of glycogen synthetase kinase 3beta (GSK3beta), which mimic Wnt signaling, may also have a therapeutic benefit by enhancing in vitro osteogenesis despite the presence of Dkk-1. Antibodies that block Dkk-1 and GSK3beta inhibitors may provide novel opportunities for the enhancement of bone repair in a variety of human diseases such as multiple myeloma and osteosarcoma.

Author-supplied keywords

  • Bone
  • Cancer
  • Dkk-1
  • Mesenchymal stem cells
  • Osteogenesis
  • Wnt

Get free article suggestions today

Mendeley saves you time finding and organizing research

Sign up here
Already have an account ?Sign in

Find this document

Get full text

Authors

  • William GunnElsevier Inc

    Follow
  • Carl A. Gregory

  • Emigdio Reyes

  • Angela J. Smolarz

  • James Munoz

  • Jeffrey L. Spees

Cite this document

Choose a citation style from the tabs below

Save time finding and organizing research with Mendeley

Sign up for free